Medeka - Company finances
|
EUR
|
2018
From: 2018-02-21
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,738 | - | 86,453 | 65,025 | 20,130 | 20,610 | 7,669 | 6,173 |
| Profit before tax | - | 0 | 28,873 | -6,824 | -7,467 | -1,923 | -6,211 | -2,524 |
| Net profit | -10,166 | 0 | 27,225 | -6,824 | -7,467 | -1,923 | -6,211 | -2,524 |
| Equity | 8,397 | 0 | 15,280 | 8,506 | 1,039 | -884 | -7,094 | -9,618 |
| Liabilities | 8,423 | - | - | - | 32,454 | 23,030 | 23,420 | 18,311 |
| Non-current assets | 13,763 | 0 | 7,769 | 37,431 | 28,049 | 20,588 | 15,667 | 8,634 |
| Current assets | 3,057 | 0 | 12,740 | 16,894 | 5,444 | 1,558 | 659 | 59 |
| Total assets | 16,820 | 0 | 20,509 | 54,325 | 33,493 | 22,146 | 16,326 | 8,693 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,802 | 16 | 60 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | -24.8% | -69.0% | +2.4% | -62.8% | -19.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -60.4% | - | 132.7% | -12.6% | -22.3% | -8.7% | -38.0% | -29.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -121.1% | - | 178.2% | -80.2% | -718.7% | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -272.0% | - | 31.5% | -10.5% | -37.1% | -9.3% | -81.0% | -40.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 33.4% | -10.5% | -37.1% | -9.3% | -81.0% | -40.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | - | - | - | 31.2 | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medeka - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-03-05 | 2024-04-30 | 586.30 |
| 2023-12-01 | 2024-01-31 | 175.89 |
| 2023-11-03 | 2023-11-30 | 117.26 |
| 2023-10-03 | 2023-11-02 | 58.63 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
| 2023-07-03 | 2023-07-31 | 234.52 |
| 2023-06-01 | 2023-07-02 | 175.89 |
| 2023-05-04 | 2023-05-31 | 117.26 |
| 2023-05-02 | 2023-05-03 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2023-03-01 | 2023-03-31 | 117.26 |
| 2023-02-01 | 2023-02-28 | 58.63 |
| 2023-01-03 | 2023-01-31 | 152.85 |
| 2022-12-01 | 2023-01-02 | 101.90 |
| 2022-11-07 | 2022-11-30 | 50.95 |
| 2022-11-03 | 2022-11-06 | 101.90 |
| 2022-10-03 | 2022-11-02 | 50.95 |
| 2022-09-01 | 2022-09-30 | 203.80 |
| 2022-08-02 | 2022-08-31 | 152.85 |
| 2022-07-01 | 2022-08-01 | 101.90 |
| 2022-05-03 | 2022-06-30 | 50.95 |
| 2022-02-01 | 2022-04-30 | 50.95 |
| 2022-01-03 | 2022-01-31 | 44.81 |
| 2021-12-01 | 2021-12-31 | 44.81 |
| 2021-11-26 | 2021-11-30 | 52.13 |
Medeka - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-03 | 2026-03-22 | 0.28 |
| 2026-01-29 | 2026-01-30 | 260.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medeka, MB (code 304773951) is a Small partnership engaged in Manufacture of other non-metallic mineral products n.e.c. In the latest financial year, 2025, the company generated EUR 6.2K in revenue and recorded a net loss of EUR 2.5K, giving a profit margin of -40.9%. Revenue continued to decline year on year, falling by 19.5% from 2024 and by 70.0% over two years, down from EUR 20.6K in 2023 to EUR 7.7K in 2024 and EUR 6.2K in 2025. Losses widened in 2024 before narrowing in 2025, but the business remained unprofitable throughout the period. The balance sheet also weakened: total assets decreased from EUR 22.1K in 2023 to EUR 16.3K in 2024 and EUR 8.7K in 2025, while equity stayed negative and moved to EUR -9.6K in 2025. Liabilities were EUR 18.3K at year-end 2025. Asset turnover was 0.71x in 2025, indicating limited revenue generation relative to the asset base, while negative equity makes ratio-based profitability measures less meaningful.